
CNXC Stock Forecast & Price Target
CNXC Analyst Ratings
Bulls say
Concentrix is currently facing headwinds in some verticals, such as healthcare, tech/consumer electronics, and small business and creator segments, causing a reduction in its fiscal 2026 and 2027 EPS forecasts. This has led to a decrease in the company's valuation multiple and a reduction in the 12-month price target to $30 from $38. However, the iX unit economics are showing promising results, with potential growth in revenue and margins. With a strong competitive position and potential for market and wallet share gains, Concentrix's performance is expected to improve in the future.
Bears say
Concentrix is heavily dependent on one segment, with a lack of diversification in other industries, leaving the company vulnerable to economic and sector-specific trends. The recent increase in headwinds will negatively impact Concentrix's operations as clients shift work offshore and pull support for certain client segments. Additionally, despite the company's acquisition strategy, there is no guarantee of success and the company's growth may be slower than expected. The company's financial performance in the second quarter of 2026 was less than stellar, with lower earnings and profit margins. The company's balance sheet is also cause for concern, with high levels of debt and a lower cash balance.
This aggregate rating is based on analysts' research of Concentrix Corporation and is not a guaranteed prediction by Public.com or investment advice.
CNXC Analyst Forecast & Price Prediction
Start investing in CNXC
Order type
Buy in
Order amount
Est. shares
0 shares